Hemolytic anemia during cyclofenil treatment of scleroderma.
D000743:Anemia, Hemolytic / Q000139:chemically induced*; D002986:Clinical Trials as Topic; D003408:Cresols / Q000009:adverse effects*; D003506:Cyclofenil / Q000009:adverse effects*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008875:Middle Aged; D010919:Placebos; D012595:Scleroderma, Systemic / Q000188:drug therapy*
D003408:Cresols; D010919:Placebos; D003506:Cyclofenil